These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37405518)

  • 21. Prognostic role and correlation of CA9, CD31, CD68 and CD20 with the desmoplastic stroma in pancreatic ductal adenocarcinoma.
    Diana A; Wang LM; D'Costa Z; Azad A; Silva MA; Soonawalla Z; Allen P; Liu S; McKenna WG; Muschel RJ; Fokas E
    Oncotarget; 2016 Nov; 7(45):72819-72832. PubMed ID: 27637082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Artificial intelligence-based comprehensive analysis of immune-stemness-tumor budding profile to predict survival of patients with pancreatic adenocarcinoma.
    Zhou T; Man Q; Li X; Xie Y; Hou X; Wang H; Yan J; Wei X; Bai W; Liu Z; Liu J; Hao J
    Cancer Biol Med; 2023 Mar; 20(3):196-217. PubMed ID: 36971107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reshaping the Immune Microenvironment by Oncolytic Herpes Simplex Virus in Murine Pancreatic Ductal Adenocarcinoma.
    Zhang L; Wang W; Wang R; Zhang N; Shang H; Bi Y; Chen D; Zhang C; Li L; Yin J; Zhang H; Cao Y
    Mol Ther; 2021 Feb; 29(2):744-761. PubMed ID: 33130310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy.
    Di Caro G; Cortese N; Castino GF; Grizzi F; Gavazzi F; Ridolfi C; Capretti G; Mineri R; Todoric J; Zerbi A; Allavena P; Mantovani A; Marchesi F
    Gut; 2016 Oct; 65(10):1710-20. PubMed ID: 26156960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer.
    Lu J; Xu Y; Wu Y; Huang XY; Xie JW; Wang JB; Lin JX; Li P; Zheng CH; Huang AM; Huang CM
    BMC Cancer; 2019 Sep; 19(1):920. PubMed ID: 31521128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocytes in the tumor microenvironment in pancreatic cancer.
    Sasaki K; Takano S; Tomizawa S; Miyahara Y; Furukawa K; Takayashiki T; Kuboki S; Takada M; Ohtsuka M
    J Exp Clin Cancer Res; 2021 Jun; 40(1):212. PubMed ID: 34167573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic biomarkers related to tumoral microenvironment in pancreatic ductal adenocarcinoma: a systematic review.
    Constantin AL; Cazacu IM; Stroescu C; Copăescu C; Săftoiu A
    Rom J Morphol Embryol; 2021; 62(3):671-678. PubMed ID: 35263394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma.
    Tang R; Liu X; Liang C; Hua J; Xu J; Wang W; Meng Q; Liu J; Zhang B; Yu X; Shi S
    Front Immunol; 2021; 12():648917. PubMed ID: 33777046
    [No Abstract]   [Full Text] [Related]  

  • 29. Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma.
    Askan G; Sahin IH; Chou JF; Yavas A; Capanu M; Iacobuzio-Donahue CA; Basturk O; O'Reilly EM
    BMC Cancer; 2021 Apr; 21(1):385. PubMed ID: 33836674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophages-based immune-related risk score model for relapse prediction in stage I-III non-small cell lung cancer assessed by multiplex immunofluorescence.
    Wu XR; Peng HX; He M; Zhong R; Liu J; Wen YK; Li CC; Li JF; Xiong S; Yu T; Zheng HB; Chen YH; He JX; Liang WH; Cai XY
    Transl Lung Cancer Res; 2022 Apr; 11(4):523-542. PubMed ID: 35529784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU).
    Hosen SMZ; Uddin MN; Xu Z; Buckley BJ; Perera C; Pang TCY; Mekapogu AR; Moni MA; Notta F; Gallinger S; Pirola R; Wilson J; Ranson M; Goldstein D; Apte M
    Front Immunol; 2022; 13():1060957. PubMed ID: 36591282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic Cancer Microenvironment and Cellular Composition: Current Understandings and Therapeutic Approaches.
    Truong LH; Pauklin S
    Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Immune Landscape of Human Pancreatic Ductal Carcinoma: Key Players, Clinical Implications, and Challenges.
    Muller M; Haghnejad V; Schaefer M; Gauchotte G; Caron B; Peyrin-Biroulet L; Bronowicki JP; Neuzillet C; Lopez A
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Paradoxical Role for Regulatory T Cells in the Tumor Microenvironment of Pancreatic Cancer.
    Brouwer T; Ijsselsteijn M; Oosting J; Ruano D; van der Ploeg M; Dijk F; Bonsing B; Fariña A; Morreau H; Vahrmeijer A; Miranda N
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of a metastasis-related Gene Signature for predicting the Overall Survival in patients with Pancreatic Ductal Adenocarcinoma.
    Wu M; Li X; Liu R; Yuan H; Liu W; Liu Z
    J Cancer; 2020; 11(21):6299-6318. PubMed ID: 33033514
    [No Abstract]   [Full Text] [Related]  

  • 36. Tumor Microenvironment in Pancreatic Intraepithelial Neoplasia.
    Opitz FV; Haeberle L; Daum A; Esposito I
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
    Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
    Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of tumor-associated N1/N2 neutrophil plasticity in patients following radical resection of pancreas ductal adenocarcinoma.
    Chen Q; Yin H; Liu S; Shoucair S; Ding N; Ji Y; Zhang J; Wang D; Kuang T; Xu X; Yu J; Wu W; Pu N; Lou W
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36600557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The resurgence of the Adora2b receptor as an immunotherapeutic target in pancreatic cancer.
    Strickland LN; Faraoni EY; Ruan W; Yuan X; Eltzschig HK; Bailey-Lundberg JM
    Front Immunol; 2023; 14():1163585. PubMed ID: 37187740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD206
    Heng Y; Zhu X; Lin H; Jingyu M; Ding X; Tao L; Lu L
    J Transl Med; 2023 Mar; 21(1):167. PubMed ID: 36864443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.